<DOC>
	<DOCNO>NCT00260923</DOCNO>
	<brief_summary>This study people diagnose hypertension compare 3 dos ( 75 mg , 150 mg , 300 mg ) experimental product , aliskiren comparison placebo . Each patient study 8 week</brief_summary>
	<brief_title>A Dose Ranging Study Compare Safety Efficacy Aliskiren Patients With High Blood Pressure</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Male female outpatient 18 year age old Patients eligible able participate study Severe hypertension History evidence secondary form hypertension History hypertensive encephalopathy cerebrovascular accident . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>hypertension</keyword>
	<keyword>aliskiren</keyword>
	<keyword>blood pressure</keyword>
</DOC>